MedTrace Logo

A Culturally Targeted Transplant Program

NCT03276390 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11836

Last updated 2022-10-03

No results posted yet for this study

Summary

Hispanic/Latino patients with end-stage renal disease are disproportionately less likely to get a kidney transplant, and specifically, a living donor kidney transplant (LDKT), compared to non-Hispanic whites. Accordingly, without LDKTs, Hispanics experience longer transplant waiting times, shorter patient and graft survival, and worse quality of life. Cultural beliefs and linguistic barriers contribute to the disparity in LDKTs. The objective of the proposed study is to implement and evaluate Northwestern Medicine's® Hispanic Kidney Transplant Program, a culturally-competent transplant center-based intervention, at two transplant centers serving large Hispanic populations. The proposed study will provide valuable knowledge about the potential to rapidly disseminate the HKTP as a novel approach to increase Hispanic LDKTs nationally.

Conditions

  • ESRD

Interventions

BEHAVIORAL

Hispanic Kidney Transplant Program (HKTP)

The HKTP entails culturally targeted education in Spanish about transplantation, outreach to dialysis patients by bicultural health care providers.

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER

  • Baylor Health Care System

    collaborator OTHER

  • University of Colorado, Denver

    collaborator OTHER

  • The Methodist Hospital Research Institute

    collaborator OTHER

  • Northwestern University

    lead OTHER

Principal Investigators

  • Elisa J Gordon, PhD · Northwestern University

  • Juan Carlos J Caicedo, MD · Northwestern University

Study Design

Allocation
NON_RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-18
Primary Completion
2021-02-28
Completion
2021-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03276390 on ClinicalTrials.gov